Jacob Ludington, MD, PhD, of Tufts Medical Center, has been presented with the 2021 Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis. This honor, which is part of the Outstanding Abstract Achievement Award program, is granted to a trainee who is the first author and presenter of the highest-scoring abstract submitted in the field of hemostasis and thrombosis. It is made possible by the Mary Rodes Gibson Hemostasis-Thrombosis Foundation to continue the legacy of Mary Rodes Gibson, who lived with severe, type 3 von Willebrand disease.
Dr. Ludington was a postdoctoral fellow in the Division of Hemostasis and Thrombosis at Beth Israel Deaconess Medical Center when he began to work on this abstract and is currently resident physician in the Department of Pathology and Laboratory Medicine at Tufts Medical Center. Upon receiving this award, Dr. Ludington expressed surprise and a felt supported by the community, saying, “I was certainly surprised when I heard the news. It was validating that experts find the work to be so compelling.” Indicating the importance of collaboration, he added, “More than anything, I felt incredibly proud to receive that kind of recognition, not only for myself, but for my PI Sol Schulman, the entire Shulman lab, Schwartz lab, and everyone else who contributed to the project.” Dr. Ludington is excited about the positive impact the award will have on his professional career path.
Dr. Ludington will present his abstract titled “SARS-CoV-2 Ion Channel ORF3a Enables TMEM16F-Dependent Phosphatidylserine Externalization to Augment Procoagulant Activity of the Tenase and Prothrombinase Complexes” (abstract 1) on Sunday, December 12, at 2:00 p.m. Eastern time (available later on demand), in Rooms B211-B212 of the Georgia World Congress Center, during the Plenary Scientific Session.
Learn more about ASH award programs, including abstract achievement awards, at www.hematology.org/awards.